https://orcid.org/0000-0002-2368-1510
References
- Affordable Care Act: Healthcare.gov; 2021 [cited 2021 Dec 26]. Available from: https://www.healthcare.gov/glossary/affordable-care-act/
- Cohen RA, Terlizzi EP, Cha AE, et al. Health insurance coverage: early release of estimates from the National Health Interview Survey, January–June 2020. USA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, 2021.
- Banegas MP, Guy GP Jr., de Moor JS, et al. For working-age cancer survivors, medical debt and bankruptcy create financial hardships. Health Aff. 2016;35(1):54–61.
- Cha A, Cohen RA. Reasons for being uninsured among adults aged 18–64 in the United States, 2019; 2020.
- Hsiang WR, Lukasiewicz A, Gentry M, et al. Medicaid patients have greater difficulty scheduling health care appointments compared with private insurance patients: a meta-analysis. Inquiry. 2019;56:46958019838118.
- Hong YR, Holcomb D, Bhandari M, et al. Affordable care act: comparison of healthcare indicators among different insurance beneficiaries with new coverage eligibility. BMC Health Serv Res. 2016;16(1):114.
- Krakora R, Shih W, Popli P, et al. Impact of insurance status on survival outcomes in adults with acute lymphoblastic leukemia (ALL): a single-center experience. Clin Lymphoma Myeloma Leuk. 2020;20(11):e890–e896.
- Abrahão R, Ribeiro RC, Medeiros BC, et al. Disparities in early death and survival in children, adolescents, and young adults with acute promyelocytic leukemia in California. Cancer. 2015;121(22):3990–3997.
- Master S, Munker R, Shi Z, et al. Insurance status and other non-biological factors predict outcomes in acute myelogenous leukemia: analysis of data from the National Cancer Database. Anticancer Res. 2016;36(9):4915–4921.
- Perry AM, Brunner AM, Zou T, et al. Association between insurance status at diagnosis and overall survival in chronic myeloid leukemia: a population-based study. Cancer. 2017;123(13):2561–2569.
- About the National Cancer Database; 2017 [cited 2022 Feb 12]. Available from: https://www.facs.org/quality-programs/cancer/ncdb/about
- Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
- Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–619.
- Dhakal P, Chen B, Giri S, et al. Effects of center type and socioeconomic factors on early mortality and overall survival of diffuse large B-cell lymphoma. Future Oncol. 2019;15(18):2113–2124.
- Bhatt VR, Shostrom V, Giri S, et al. Early mortality and overall survival of acute myeloid leukemia based on facility type. Am J Hematol. 2017;92(8):764–771.
- Dhakal P, Lyden E, Rajasurya V, et al. Early mortality and overall survival in acute promyelocytic leukemia: do real-world data match results of the clinical trials? Leuk Lymphoma. 2021;12:1–9.
- Bhatt VR, Shostrom V, Holstein SA, et al. Survival of older adults with newly diagnosed acute myeloid leukemia: effect of using multiagent versus single-agent chemotherapy. Clin Lymphoma Myeloma Leuk. 2020;20(5):e239–e258.
- Subramanian S. Impact of medicaid copayments on patients with cancer: lessons for medicaid expansion under health reform. Med Care. 2011;49(9):842–847.
- Shen C, Zhao B, Zhou S, et al. Low income subsidy status outweighs insurance cost-sharing in predicting adherence to tyrosine kinase inhibitors among medicare part D beneficiaries with chronic myeloid leukemia. J Clin Oncol. 2016;34(15_suppl):6531–6531.
- Medicare; 2022 [cited 2022 Mar 13]. Available from: https://www.medicare.gov/
- Stubbins RJ, Stamenkovic M, Roy C, et al. Incidence and socioeconomic factors in older adults with acute myeloid leukaemia: real-world outcomes from a population-based cohort. Eur J Haematol. 2022;108(5):437–445.